Citation: | Le HU, Yuyang LI, Zhiyong KE, Yue ZHANG, Wuju ZHANG. A preliminary study of conditional limb bud mesenchymal stem cell FKBP38 knockout mice[J]. Journal of Molecular Imaging, 2019, 42(1): 67-69. doi: 10.12122/j.issn.1674-4500.2019.01.16 |
[1] |
Glyn-Jones S, Palmer AJ, Agricola R, et al. Osteoarthritis[J]. Lancet, 2015, 386(91): 376-87
|
[2] |
Hwang HS, Kim HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis[J]. Int J Mol Sci, 2015, 16(11): 26035-54
|
[3] |
Aigner T, Kim HA. Apoptosis and cellular vitality - Issues in osteoarthritic cartilage degeneration[J]. Arthritis Rheum, 2002, 46(8): 1986-96
|
[4] |
Battistelli M, Salucci S, Olivotto E, et al. Cell death in human articular chondrocyte: a morpho-functional study in micromass model[J]. Apoptosis, 2014, 19(10): 1471-83
|
[5] |
Feac C. From cell death to viral replication: the diverse functions of the membrane-associated FKBP38 Frank Edlich1 and Christian Lücke2[J]. Curr Opin Pharmacol, 2011, 11(3): 348-53
|
[6] |
Kang CB, Hong Y, Dhe-Paganon S. et al: FKBP family proteins: immunophilins with versatile biological function[J]. Neurosignals, 2008, 16(4): 318-25
|
[7] |
Bai XC, Ma DZ, Liu AL, et al. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38[J]. Science, 2007, 318(5852): 977-80
|
[8] |
Wang JD, Tong WY, Zhang XN, et al. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells[J]. FEBS Lett, 2006, 580(18): 4392-400
|
[9] |
Shirane M, Nakayama KI. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis[J]. Nat Cell Biol, 2003, 5(1): 28-37
|
[10] |
Shirane M, Ogawa M, Motoyama J, et al. Regulation of apoptosis and neurite extension by FKBP38 is required for neural tube formation in the mouse[J]. Genes to Cells, 2008, 13(6): 635-51
|
[11] |
王 帅, 赖姨梅, 林 艳. 等: FKBP38肝脏特异敲除小鼠模型的构建[J]. 现代生物医学进展, 2017, 17(26): 5001-6
|
[12] |
Misaka T, Murakawa T, Nishida K, et al. FKBP8 protects the heart from hemodynamic stress by preventing the accumulation of misfolded proteins and endoplasmic reticulum-associated apoptosis in mice[J]. J Mol Cell Cardiol, 2018, 114(1): 93-104
|
[13] |
李 涛, 卢圣栋. 时空特异性基因打靶的应用及有关进展[J]. 生物工程进展, 2002, 37(2): 56-60
|
[14] |
Frank EM, Erdmann J, Jarczowski JR, et al. Bcl-2 regulator FKBP38 is activated by Ca2þ/calmodulin[J]. Embo J, 2005, 24(7): 2688-99
|
[15] |
Robert A. Saxton ADMS: mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, (168): 960-76
|
[16] |
许颖, 范凯健, 王婷玉. 骨关节炎的发病机制及其药物治疗进展[J]. 实用药物与临床, 2018, 42(12): 1424-9
|
[17] |
娄思权. 骨关节炎的病理与发病因素[J]. 中华骨科杂志, 1996, 15(1): 57-60
|
[18] |
邱贵兴. 骨关节炎诊治指南(2007年版)[J]. 中华关节外科杂志: 电子版, 2007, 1(4): 281-5
|